[Skip to Navigation]
Sign In
Editorial
May 10, 2016

Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder

Author Affiliations
  • 1Section on Neurobehavioral Clinical Research, Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, Maryland
  • 2National Institute of Mental Health, Bethesda, Maryland
JAMA. 2016;315(18):1953-1955. doi:10.1001/jama.2016.3427
Add or change institution
×